Skip to content
Screener

AbCellera Biologics Inc. ABCL EBITDA

EBITDA at other companies

Schrodinger logo
SchrodingerSDGR
-$40.06M+22.0%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
-$39.45M-12.2%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$116.8M+23.3%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$46.23M-7.7%
Absci Corporation logo
Absci CorporationABSI
-$28.12M-14.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$31.5M-64.2%

Other financials

Income statement

See full
Revenue$4.1M-76.3%
Operating income-$62.8M-26.6%
Net income-$55.4M-59.6%
EPS (diluted)-$0.18-50.0%

Balance sheet

See full
Cash & equivalents$145.1M+23.5%
Total debt$135.6M-4.5%
Total equity$896.0M-11.0%
Total assets$1.3B-6.7%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$2.1M-84.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.99B+62.2%
Enterprise value$1.98B+58.2%
P/S30.1×-7.3×

Profitability

See full
Operating margin-340.3%-127pp
Net margin-248.8%-83.6pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-17.3%+2.1pp
Debt / equity0.2×0.0×
Current ratio12.8×+1.7×

Where this comes from

Calculated from AbCellera Biologics Inc.’s reported figures.

−$62.8Mebit+
$7.0MDepreciation Depletion & Amortization
=-$55.79M

The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001703057-26-000046

FAQ

What is AbCellera Biologics Inc.'s EBITDA?
AbCellera Biologics Inc. (ABCL) reported EBITDA of -$55.79M in Q2 2026.
How has AbCellera Biologics Inc.'s EBITDA changed year-over-year?
AbCellera Biologics Inc.'s EBITDA decreased by 26.5% year-over-year, from -$44.12M to -$55.79M.
What is the long-term trend for AbCellera Biologics Inc.'s EBITDA?
Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s EBITDA has grown at a -3.8% compound annual growth rate (CAGR), from $218.95M to -$194.97M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about AbCellera Biologics Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude